Problems and prospects of implementing harm reduction for HIV and injecting drug use in high risk sub-Saharan African countries

被引:13
作者
Adelekan, ML
Stimson, GV
机构
[1] CHARING CROSS & WESTMINSTER MED SCH, ACAD DEPT PSYCHIAT, CTR RES DRUGS & HLTH BEHAV, LONDON SW6 1RQ, ENGLAND
[2] UNIV ILORIN, TEACHING HOSP, ILORIN, NIGERIA
关键词
D O I
10.1177/002204269702700107
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
The use and misuse of a broad spectrum of psychoactive substances, including heroin and cocaine, is of growing concern in many African countries. Approximately one-third of global HIV and AIDS cases are reported from Africa but injecting drug use has not yet been documented as a causative factor. The drug supply control strategy has recorded only limited success in Africa, and the currently adopted demand reduction programs are beset with many problems. In this paper we review possible constraining and facilitating factors in the adoption of harm reduction approaches in high risk sub-Saharan African countries. We conclude that appropriate needs assessments are urgently required to establish the extent of problem drug use and of injecting. This exercise may identify clinical and psychosocial problems that could benefit from an intervention approach based on a combination of the principles of harm reduction and demand reduction.
引用
收藏
页码:97 / 116
页数:20
相关论文
共 67 条
[61]  
STIMSON GV, 1996, INT J DRUG POLICY, V7, P246
[62]  
Strang John, 1993, PSYCHOACTIVE DRUGS H, P3
[63]  
*UN DRUG CONTR PRO, 1994, EXAMINATION WORLD SI
[64]  
*UN DRUG CONTR PRO, 1994, REP EXP FOR DEM RED
[65]  
VANDEWALLE E, 1990, MILBANK Q S1, V68, P11
[66]  
*WHO GLOB AIDS STA, 1995, AIDS CARE, V7, P111
[67]  
WODAK A, 1993, PSYCHOACTIVE DRUGS H